biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".white house to ban federal funds for clinics that discuss abortion with patients : the two-way.
orchid pharma faces liquidation as lenders reject resolution plan
.
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)...